2/4
08:15 am
axgn
Wasatch Micro Cap Fund Q4 2025 Commentary [Seeking Alpha]
Medium
Report
Wasatch Micro Cap Fund Q4 2025 Commentary [Seeking Alpha]
1/24
03:28 pm
axgn
A Look At Axogen (AXGN) Valuation After Its Upsized US$124 Million Equity Offering [Yahoo! Finance]
Medium
Report
A Look At Axogen (AXGN) Valuation After Its Upsized US$124 Million Equity Offering [Yahoo! Finance]
1/24
12:36 am
axgn
Axogen (AXGN) Is Up 5.8% After Upsized Equity Raise and Debt Paydown - What's Changed [Yahoo! Finance]
Medium
Report
Axogen (AXGN) Is Up 5.8% After Upsized Equity Raise and Debt Paydown - What's Changed [Yahoo! Finance]
1/22
06:48 am
axgn
Axogen stock dips after pricing $124M offering [Seeking Alpha]
Medium
Report
Axogen stock dips after pricing $124M offering [Seeking Alpha]
1/22
12:01 am
axgn
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock [Yahoo! Finance]
Medium
Report
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock [Yahoo! Finance]
1/21
11:18 pm
axgn
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
Medium
Report
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
1/21
05:50 pm
axgn
Axogen Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
Medium
Report
Axogen Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
1/21
04:09 pm
axgn
Axogen Announces Proposed Public Offering of Common Stock
Low
Report
Axogen Announces Proposed Public Offering of Common Stock
1/15
03:21 pm
axgn
AxoGen Touts Post-BLA Growth Plan, 75%+ Gross Margin Outlook at J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
AxoGen Touts Post-BLA Growth Plan, 75%+ Gross Margin Outlook at J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/14
07:45 am
axgn
Axogen CEO Axed 25,000 Shares From His Direct Holdings [Yahoo! Finance]
Low
Report
Axogen CEO Axed 25,000 Shares From His Direct Holdings [Yahoo! Finance]
1/12
07:20 am
axgn
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025 [Yahoo! Finance]
Medium
Report
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025 [Yahoo! Finance]
1/12
07:00 am
axgn
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
Medium
Report
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
1/7
11:51 am
axgn
Should You Think About Buying Axogen, Inc. (NASDAQ:AXGN) Now? [Yahoo! Finance]
Low
Report
Should You Think About Buying Axogen, Inc. (NASDAQ:AXGN) Now? [Yahoo! Finance]
12/22
06:33 am
axgn
Are Investors Undervaluing Axogen, Inc. (NASDAQ:AXGN) By 31%? [Yahoo! Finance]
Medium
Report
Are Investors Undervaluing Axogen, Inc. (NASDAQ:AXGN) By 31%? [Yahoo! Finance]
12/17
07:00 am
axgn
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
Medium
Report
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
12/5
12:14 pm
axgn
AxoGen (NASDAQ:AXGN) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
AxoGen (NASDAQ:AXGN) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/5
08:43 am
axgn
AxoGen (NASDAQ:AXGN) was given a new $37.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
AxoGen (NASDAQ:AXGN) was given a new $37.00 price target on by analysts at Canaccord Genuity Group Inc..
12/4
03:07 pm
axgn
AxoGen (NASDAQ:AXGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
AxoGen (NASDAQ:AXGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
12/4
09:08 am
axgn
AxoGen (NASDAQ:AXGN) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
Medium
Report
AxoGen (NASDAQ:AXGN) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
12/4
08:04 am
axgn
AxoGen (NASDAQ:AXGN) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
High
Report
AxoGen (NASDAQ:AXGN) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
12/3
11:41 pm
axgn
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) [Yahoo! Finance]
Medium
Report
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) [Yahoo! Finance]
12/3
08:01 pm
axgn
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
Medium
Report
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
12/3
07:57 am
axgn
AxoGen (NASDAQ:AXGN) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Low
Report
AxoGen (NASDAQ:AXGN) was upgraded by analysts at Mizuho to a "strong-buy" rating.
12/1
12:40 pm
axgn
Avance Nerve Graft FDA Verdict Approaches, Why Investors Are Watching Axogen [Seeking Alpha]
Low
Report
Avance Nerve Graft FDA Verdict Approaches, Why Investors Are Watching Axogen [Seeking Alpha]
12/1
07:19 am
axgn
AxoGen (NASDAQ:AXGN) was given a new $40.00 price target on by analysts at Mizuho.
Low
Report
AxoGen (NASDAQ:AXGN) was given a new $40.00 price target on by analysts at Mizuho.